in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/Fine Chemicals Roundup – August 2
8:21 AM MDT | August 2, 2011 | Deepti Ramesh
LONZA REPORTS FALL IN FIRST-HALF PROFITS AND SALES Lonza has recorded a 28% fall in first-half profits compared with the year-ago period, to SF97 million ($120 million), and Ebitda decreased by 14%, to SF265 million. Sales decreased 8%, to SF1.19 billion, mainly due to the negative currency exchange rate, Lonza says. “Despite the heavy hit we have taken in our reported numbers as a result of the strong Swiss franc, I am pleased that the company has delivered 5% growth in underlying revenues and operating profits,” says Stefan Borgas, CEO of Lonza...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee